A detailed history of Tcg Crossover Management, LLC transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 1,555,118 shares of ANTX stock, worth $3.22 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
1,555,118
Previous 2,678,209 41.93%
Holding current value
$3.22 Million
Previous $54.9 Million 90.79%
% of portfolio
0.53%
Previous 7.59%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.78 - $21.53 $3.12 Million - $24.2 Million
-1,123,091 Reduced 41.93%
1,555,118 $5.05 Million
Q3 2023

Nov 14, 2023

BUY
$7.58 - $16.08 $10.5 Million - $22.3 Million
1,388,889 Added 107.72%
2,678,209 $43.1 Million
Q2 2023

Aug 14, 2023

BUY
$5.06 - $9.91 $6.52 Million - $12.8 Million
1,289,320 New
1,289,320 $11 Million

Others Institutions Holding ANTX

About AN2 Therapeutics, Inc.


  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $40.2M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.